Retatrutide, by Soma, represents a significant breakthrough in body management . This dual-action drug combines hormonal receptor function with GIP pathway activation , showing substantial efficacy in patient data for weight reduction . Experts believe Retatrutide may provide a new option for patients experiencing weight-related conditions . Soma C